UNSPSC 85722812: Revision of autologous tissue substitute in right ankle joint, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in right ankle joint, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SWFX7Z

UNSPSC 85722812 Revision of autologous tissue substitute in right ankle joint, external approach is a Commodity code that does not align with recent state and local procurement activity. The code nominally describes a specific orthopedic surgical procedure — revision of tissue-engineered joint repair — but the recent solicitations tagged under this code span occupational medical surveillance, disability medical record review and independent medical evaluations, surgical benefit carve-out programs, pharmacy benefit management, temporary health professional staffing, specialty and emergency medical services for detained youth, and related administrative health services. None of these activities involve orthopedic implant procurement, surgical revision procedures, or the clinical work the code's name describes.

The mismatch suggests either a data-tagging error in the state and local procurement system or that this code is being used as a placeholder for broad health services categories without specificity. The actual issuing bodies represent diverse public sectors: city retirement boards (Phoenix), municipal human resources (Long Beach), state transportation agencies (Washington State Ferries), county juvenile detention (Harris County), county employee health consortia (Collier County), and county health systems (Santa Clara). The geographic spread spans Arizona, California, Florida, Washington, and Texas. No recent opportunities show procurement of autologous tissue substitutes, orthopedic implants, or surgical revision services. Business development professionals pursuing this code should treat it as inactive for its nominal clinical scope and verify code accuracy with procurement offices before bid strategy decisions.